SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-066190
Filing Date
2011-03-15
Accepted
2011-03-14 20:56:14
Documents
40
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1286346
2 AMENDED AND RESTATED BYLAWS OF AVI BIOPHARMA dex34.htm EX-3.4 64256
3 FORM OF SPECIMAN CERTIFICATE FOR COMMON STOCK dex41.htm EX-4.1 725
4 AMENDMENT TO EMPLOYMENT AGREEMENT WITH DWIGHT WELLER dex102.htm EX-10.2 9211
5 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT WITH DWIGHT WELLER dex103.htm EX-10.3 12952
6 AMENDMENT TO EMPLOYMENT AGREEMENT WITH PATRICK IVERSEN PH.D. dex105.htm EX-10.5 9079
7 AMENDMENT NO. 2 TO EMPLOYMENT WITH PATRICK IVERSEN, PH.D. dex106.htm EX-10.6 12808
8 AMENDMENT TO EMPLOYMENT AGREEMENT WITH DR. RYSZARD KOLE dex109.htm EX-10.9 12449
9 EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA AND DAVID BOYLE II dex1010.htm EX-10.10 63354
10 AMENDMENT NO.1 TO EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA & J.DAVID BOYLE II dex1011.htm EX-10.11 19900
11 AMENDMENT NO.2 TO EMPLOYMENT AGREEMENT WITH J. DAVID BOYLE II dex1012.htm EX-10.12 9866
12 AMENDMENT NO.1 TO EMPLOYMENT AGREEMENT WITH STEPHEN BEVAN SHREWSBERRY, M.D. dex1014.htm EX-10.14 9085
13 EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA AND PAUL MEDEIROS dex1015.htm EX-10.15 118899
14 AMENDMENT TO EMPLOYMENT AGREEMENT WITH PAUL MEDEIROS dex1016.htm EX-10.16 8929
15 EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN AVI BIOPHARMA & CHRISTOPHER GERABEDIAN dex1017.htm EX-10.17 62297
16 OFFER LETTER BETWEEN AVI BIOPHARMA, INC. AND GRAHAM JOHNSON B.SC.,PH.D. dex1018.htm EX-10.18 26789
17 EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN UNIVERSITY OF WESTERN AUSTRALIA & AVI dex1036.htm EX-10.36 151780
18 LEASE EXTENSION AND MODIFICATION AGREEMENT dex1053.htm EX-10.53 40172
19 LEASE BY AND BETWEEN S/I NORTH CREEK VII LLC AND AVI BIOPHARMA dex1057.htm EX-10.57 434516
20 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2413
21 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6708
22 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6516
23 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4239
24 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4242
25 GRAPHIC g147324exqp4a.jpg GRAPHIC 4039
26 GRAPHIC g147324exqp4b.jpg GRAPHIC 4134
27 GRAPHIC g147324exrp46a.jpg GRAPHIC 4745
28 GRAPHIC g147324exrp46b.jpg GRAPHIC 5409
29 GRAPHIC g147324exrp47a.jpg GRAPHIC 5397
30 GRAPHIC g147324exrp47b.jpg GRAPHIC 22374
31 GRAPHIC g147324exrp48a.jpg GRAPHIC 9781
32 GRAPHIC g147324exrp48b.jpg GRAPHIC 14700
33 GRAPHIC g147324exrp51.jpg GRAPHIC 230208
34 GRAPHIC g147324exrp52.jpg GRAPHIC 192650
35 GRAPHIC g147324exrp53.jpg GRAPHIC 98271
36 GRAPHIC g147324exrp56.jpg GRAPHIC 77126
37 GRAPHIC g147324g69h05.jpg GRAPHIC 43253
38 GRAPHIC g147324img1.jpg GRAPHIC 4632
39 GRAPHIC g147324img2.jpg GRAPHIC 274499
40 GRAPHIC g147324img3.jpg GRAPHIC 132589
  Complete submission text file 0001193125-11-066190.txt   3929395
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 11686942
SIC: 2834 Pharmaceutical Preparations